Australia TGA ARTG recordWart-removal material
Australia TGA ARTG Registered Device · Pharmacare Laboratories Pty Ltd · Medical Brands Innovations BV · Class IIa · Started July 20, 2020
Good Name: Pharmacare Laboratories Pty Ltd - Wart-removal material
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- July 20, 2020
- Effective Date
- July 20, 2020
- Country
- Netherlands
- Address
- Weesperstraat 114, AP Diemen, 1112
Wart treatment pen is intended to treat common warts (verruca vulgaris, usually located on hands and feet) and foot warts (verruca plantaris) in adults and children from 4 years old. The gel formulation is based on the active ingredient acid TCA-Active, which is applied with a fine tip, in order to remove warts from the hands and feet. It is available [non-prescription] over-the-counter (OTC).
Access comprehensive regulatory information for Wart-removal material in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Pharmacare Laboratories Pty Ltd, manufactured by Medical Brands Innovations BV in Netherlands. The device registration started on July 20, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.